Log inSign up
AAOIFI No. 21 screening

Is RCKT halal?

Rocket Pharmaceuticals, Inc.

Doubtful

No clear verdict is possible for Rocket Pharmaceuticals, Inc. — data is insufficient or the case is contested in fiqh. As a precaution it is NOT included in the halal list.

Checked: 15 October 2026

Exchange

NASDAQ

Price

2.18

Day

-7.63%

Market cap

$254.7M

Industry

Biotechnology

Sector

Healthcare

What the company does

Rocket Pharmaceuticals is a gene-therapy biotech targeting rare pediatric diseases (Danon cardiomyopathy — RP-A501, Fanconi anemia, LAD-I). No revenue; in trials.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $21.27M ÷ 36-month average market cap $1.13B = 1.9%

    1.9%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $283.75M ÷ 36-month average market cap $1.13B = 25.2%

    25.2%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    —

    No data

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $254.68M.

In the lists

In the S&P 500
Not in the S&P 500

Superinvestors

SEC 13F, 2026 Q3. Up to 45 days delayed.

Held by 1 superinvestors · Average reported price: $3.42

All superinvestor portfolios

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyRCKT's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →